down arrow

Proto Labs, Inc.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US7437131094
USD
52.08
0.4 (0.77%)

Dec 05

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

51.4952.10

52 Week

29.5955.90
Valuation
Technical
Day's Volume

CASH

49.84 k

Shareholding (Mar 2025)

FII

11.18%

Held by 105 FIIs

DII

42.22%

Held by 50 DIIs

Promoter

0.07%

How big is Proto Labs, Inc.?

22-Jun-2025

As of Jun 18, Proto Labs, Inc. has a market capitalization of 906.85 million, with net sales of 499.20 million and a net profit of 14.93 million over the latest four quarters. Shareholder's funds are 670.15 million, and total assets amount to 768.67 million.

As of Jun 18, Proto Labs, Inc. has a market capitalization of 906.85 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 499.20 million for the latest four quarters, along with a net profit of 14.93 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 670.15 million and total assets amounting to 768.67 million.

Read More

What does Proto Labs, Inc. do?

22-Jun-2025

Proto Labs, Inc. is a digital manufacturer specializing in on-demand 3D printing, CNC machining, and injection molding of custom parts. As of March 2025, it reported net sales of $126 million and a market cap of approximately $906.85 million.

Overview:<BR>Proto Labs, Inc. is an e-commerce driven digital manufacturer of on-demand 3D printed, CNC machined, and injection-molded custom parts, operating within the Specialty Chemicals industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 126 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 4 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 906.85 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 44.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.15 <BR>Return on Equity: 3.12% <BR>Price to Book: 1.38<BR><BR>Contact Details:<BR>Address: 5540 Pioneer Creek Dr, MAPLE PLAIN MN: 55359-9003 <BR>Tel: ['1 763 4797474', '1 763 4797726'] <BR>Fax: 1 763 4792679 <BR>Website: https://www.protolabs.com/

Read More

Who are in the management team of Proto Labs, Inc.?

22-Jun-2025

As of March 2022, the management team of Proto Labs, Inc. includes Mr. Sven Wehrwein (Independent Chairman), Ms. Victoria Holt, and six Independent Directors: Mr. Archie Black, Mr. Sujeet Chand, Ms. Moonhie Chin, Dr. Rainer Gawlick, and Mr. John Goodman.

As of March 2022, the management team of Proto Labs, Inc. includes the following members:<BR><BR>- Mr. Sven Wehrwein, Independent Chairman of the Board<BR>- Ms. Victoria Holt, Director<BR>- Mr. Archie Black, Independent Director<BR>- Mr. Sujeet Chand, Independent Director<BR>- Ms. Moonhie Chin, Independent Director<BR>- Dr. Rainer Gawlick, Independent Director<BR>- Mr. John Goodman, Independent Director

Read More

Is Proto Labs, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Proto Labs, Inc. shows a mildly bullish trend with mixed technical signals, having outperformed the S&P 500 year-to-date and over the past year, but underperformed over the longer 3- and 5-year periods.

As of 31 October 2025, the technical trend for Proto Labs, Inc. has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the daily moving averages also reflect bullish momentum. However, the KST shows a mildly bearish signal on the weekly timeframe. There is no clear trend indicated by Dow Theory or the OBV for both weekly and monthly periods. <BR><BR>In terms of performance, Proto Labs has outperformed the S&P 500 year-to-date and over the past year, with returns of 23.51% and 27.05% respectively, compared to the S&P 500's 16.30% and 19.89%. However, over the longer 3-year and 5-year periods, it has significantly underperformed the benchmark. Overall, the current technical stance is mildly bullish, with mixed signals from various indicators.

Read More

Is Proto Labs, Inc. overvalued or undervalued?

02-Dec-2025

As of November 28, 2025, Proto Labs, Inc. is fairly valued with a P/E ratio of 44, an EV to EBITDA of 13.93, and a Price to Book Value of 1.39, despite having underperformed over the past five years with a return of -63.30% compared to the S&P 500's 88.25%, although it has outperformed the index year-to-date with a return of 27.99%.

As of 28 November 2025, the valuation grade for Proto Labs, Inc. has moved from very expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 44, an EV to EBITDA of 13.93, and a Price to Book Value of 1.39. In comparison, peers such as Genesis Energy LP have a significantly higher P/E of 126.33, while Ecovyst, Inc. shows a much lower P/E of 18.34, indicating a broad range of valuations within the sector.<BR><BR>In terms of recent performance, Proto Labs has outperformed the S&P 500 on a year-to-date basis, returning 27.99% compared to the S&P 500's 16.45%. However, over the longer term, the company has struggled, with a 5-year return of -63.30% versus the S&P 500's 88.25%. This mixed performance reinforces the notion that while the company is currently fairly valued, its historical performance raises some concerns.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at times

 
2

Poor long term growth as Operating profit has grown by an annual rate -20.91% of over the last 5 years

 
3

Positive results in Jun 25

4

With ROE of 3.12%, it has a expensive valuation with a 1.39 Price to Book Value

5

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 1,200 Million (Small Cap)

stock-summary
P/E

44.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.15

stock-summary
Return on Equity

3.08%

stock-summary
Price to Book

1.80

Revenue and Profits:
Net Sales:
135 Million
(Quarterly Results - Jun 2025)
Net Profit:
4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.31%
0%
4.31%
6 Months
39.59%
0%
39.59%
1 Year
25.89%
0%
25.89%
2 Years
43.23%
0%
43.23%
3 Years
103.68%
0%
103.68%
4 Years
6.26%
0%
6.26%
5 Years
-61.73%
0%
-61.73%

Proto Labs, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Proto Labs, Inc. overvalued or undervalued?

As of 28 November 2025, the valuation grade for Proto Labs, Inc. has moved from very expensive to fair. The company appears to be fairly valued based on its current metrics. The P/E ratio stands at 44, while the EV to EBITDA ratio is 13.93, and the Price to Book Value is 1.39. In comparison to peers, Proto Labs has a higher P/E ratio than Ecovyst, Inc. at 18.34 and a significantly lower EV to EBITDA ratio than Genesis Energy LP at 9.69. Despite the recent shift in valuation, the stock has outperformed the S&P 500 with a year-to-date return of 30.01% compared to the S&P 500's 16.45%. However, over the longer term, the 5-year return of -63.37% indicates significant volatility and underperformance relative to the index....

Read More

Is Proto Labs, Inc. overvalued or undervalued?

As of 28 November 2025, the valuation grade for Proto Labs, Inc. has moved from very expensive to fair. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 44, the EV to EBITDA ratio is 13.93, and the Price to Book Value is 1.39. In comparison, peers such as Genesis Energy LP have a significantly higher P/E of 126.33, while Ecovyst, Inc. shows a much lower P/E of 18.34, indicating a wide range of valuations within the industry. In terms of recent performance, Proto Labs has outperformed the S&P 500 over the year with a return of 24.56% compared to the index's 14.18%. However, the company's 5-year return of -63.37% starkly contrasts with the S&P 500's 88.25%, suggesting a challenging long-term outlook despite recent improvements....

Read More

Is Proto Labs, Inc. overvalued or undervalued?

As of 21 November 2025, the valuation grade for Proto Labs, Inc. has moved from fair to very expensive, indicating that the company is overvalued. The key ratios supporting this conclusion include a P/E ratio of 44, an EV to EBITDA ratio of 13.93, and a PEG ratio of 4.96, all of which suggest that the stock is trading at a premium compared to its earnings growth potential. In comparison to peers, Proto Labs has a significantly higher P/E ratio of 58.60 when compared to Ecovyst, Inc. at 18.34, and an EV to EBITDA ratio of 19.17, which further highlights its overvaluation. Despite a strong year-to-date return of 24.92% compared to the S&P 500's 12.26%, the long-term performance shows a concerning decline, with a 5-year return of -63.67% against the S&P 500's 85.61%. This disparity reinforces the notion that Proto Labs, Inc. is currently overvalued....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.43%
EBIT Growth (5y)
-20.91%
EBIT to Interest (avg)
26.91
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.73
Tax Ratio
34.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
4.16%
ROE (avg)
3.35%
Valuation key factors
Factor
Value
P/E Ratio
44
Industry P/E
Price to Book Value
1.39
EV to EBIT
35.23
EV to EBITDA
13.93
EV to Capital Employed
1.45
EV to Sales
1.63
PEG Ratio
4.96
Dividend Yield
NA
ROCE (Latest)
4.13%
ROE (Latest)
3.12%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 66 Schemes (46.45%)

Foreign Institutions

Held by 105 Foreign Institutions (11.18%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 7.05% vs 3.61% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 22.22% vs 1,000.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "135.10",
          "val2": "126.20",
          "chgp": "7.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.70",
          "val2": "13.20",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.40",
          "val2": "3.60",
          "chgp": "22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.90%",
          "val2": "35.60%",
          "chgp": "0.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -0.60% vs 3.17% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.49% vs 116.62% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "500.90",
          "val2": "503.90",
          "chgp": "-0.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.30",
          "val2": "65.90",
          "chgp": "-6.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "1.10",
          "chgp": "-81.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.60",
          "val2": "-0.20",
          "chgp": "-2,700.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.60",
          "val2": "17.20",
          "chgp": "-3.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "50.90%",
          "val2": "56.30%",
          "chgp": "-0.54%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
135.10
126.20
7.05%
Operating Profit (PBDIT) excl Other Income
13.70
13.20
3.79%
Interest
0.00
0.00
Exceptional Items
-0.10
0.00
Consolidate Net Profit
4.40
3.60
22.22%
Operating Profit Margin (Excl OI)
37.90%
35.60%
0.23%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.05% vs 3.61% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 22.22% vs 1,000.00% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
500.90
503.90
-0.60%
Operating Profit (PBDIT) excl Other Income
61.30
65.90
-6.98%
Interest
0.20
1.10
-81.82%
Exceptional Items
-5.60
-0.20
-2,700.00%
Consolidate Net Profit
16.60
17.20
-3.49%
Operating Profit Margin (Excl OI)
50.90%
56.30%
-0.54%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -0.60% vs 3.17% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -3.49% vs 116.62% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Proto Labs, Inc. stock-summary
stock-summary
Proto Labs, Inc.
Specialty Chemicals
Proto Labs, Inc. is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company's geographic segments include the United States, Europe and Japan. The Company targets its products to the product developers and engineers who use 3D computer-aided design (3D CAD) software to design products across a range of end markets. Its product lines include Injection Molding, CNC Machining and 3D Printing. Its Injection Molding product line is used for prototype, on-demand and short-run production. Its CNC Machining product line uses commercially available CNC machines to cut plastic or metal blocks into one or more custom parts. Its 3D Printing product line includes stereolithography (SL), selective laser sintering (SLS) and direct metal laser sintering (DMLS) processes. The Company also provides low-volume sheet metal fabrication services.
Company Coordinates stock-summary
Company Details
5540 Pioneer Creek Dr , MAPLE PLAIN MN : 55359-9003
stock-summary
Tel: 1 763 47974741 763 4797726
stock-summary
https://www.protolabs.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."